Robert Bigler, MD
Pain Medicine · Lafayette, INNPI 1023078441
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.9% of the total across 286 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations.
Across 286 payments — averaging $17.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Boston Scientific$928
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$925
- Collegium Pharmaceutical, Inc.$392
- Abbott$324
- Radius Health, Inc.$213
- plus $1K from 32 others
What the payments were for
- Travel & lodging$4168%
- Food & beverage$4,70392%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 72 | $1,024 |
| Boston Scientific | 33 | $928 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 70 | $925 |
| Collegium Pharmaceutical, Inc. | 24 | $392 |
| Abbott | 8 | $324 |
| Radius Health, Inc. | 12 | $213 |
| Arbor Pharmaceuticals, Inc. | 6 | $154 |
| Pfizer | 8 | $144 |
| Biodelivery Sciences International, Inc. | 11 | $138 |
| AstraZeneca | 1 | $128 |
| Nevro Corp. | 3 | $54 |
| Almatica Pharma LLC | 2 | $47 |
| Redhill Biopharma Inc. | 2 | $47 |
| Virtus Pharmaceuticals LLC | 2 | $46 |
| Biohaven Pharmaceuticals, Inc. | 2 | $40 |
| Scilex Pharmaceuticals Inc. | 2 | $39 |
| GRT US Holding, Inc. | 3 | $36 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| MDD US Operations, LLC | 2 | $31 |
| Lundbeck LLC | 1 | $28 |
| Valinor Pharma, LLC | 2 | $27 |
| Saluda Medical Americas, Inc. | 1 | $27 |
| Kyowa Kirin, Inc. | 1 | $26 |
| Kaleo, Inc. | 2 | $26 |
| Si-bone, Inc. | 1 | $22 |
| Novartis | 1 | $21 |
| Tersera Therapeutics LLC | 1 | $20 |
| Amneal Pharmaceuticals LLC | 1 | $19 |
| Amgen | 1 | $19 |
| Vertex | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Bioventus LLC | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Painteq LLC | 1 | $15 |
| Elutia, Inc. | 1 | $15 |
| Pacira Therapeutics, Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Baudax Bio Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$191
- WaveWriter Alpha Prime 16$138
- BREZTRI$128
How this compares
$5,118 in reported general payments places this provider in the 60th percentile of 128 pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pain medicine in Lafayette
- Matthew DevriesLafayette$37K
- Shazia SiddiquiLafayette$5K
- Derron WilsonCarmel$616K
- Kevin MacadaegCarmel$337K
- Andrew TrobridgeMuncie$253K
- Meredith LanghorstFishers$233K
- Abhishek DasMishawaka$186K
- Rajiv TewariFishers$140K
- John SwoffordIndianapolis$127K
- Neal ColemanMuncie$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.